Treatment for acute myeloid leukaemia (AML)
Treatment usually begins as soon as a diagnosis has been made, and will depend on the subtype of AML, the genetic make-up of the leukaemia, and your overall health and age. Chemotherapy is the main treatment for AML. You may have further treatments depending on the subtype of AML and how you respond to the chemotherapy.
Learn more about treatment for AML:
- Making treatment decisions
- Stem cell transplant
- Low-dose drug therapy
- Targeted therapy
- Radiation therapy
- Treatment for APML
- Palliative treatment
Dr Anoop Enjeti, Senior Staff Specialist Haematologist, Calvary Mater Newcastle, and Conjoint Senior Lecturer, The University of Newcastle; Ray Araullo, Deputy Head, Social Work Department, Royal North Shore Hospital; Shehaan Fernando, Consumer; Narelle Greentree, Clinical Nurse Specialist, Hunter Haematology Unit, Calvary Mater Newcastle; Yvonne King, 13 11 20 Consultant, Cancer Council NSW; Karen Maddock, Haematology Clinical Nurse Consultant, Westmead Hospital; Melanie Sexton, Consumer; Dr Jonathan Sillar, Haematology Registrar, Calvary Mater Newcastle, and Conjoint Fellow, The University of Newcastle.
View the Cancer Council NSW editorial policy.
The information on this page is also available for download.